How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Prescription Writing Software Market
- By Product Type: Standalone Prescription Writing Software, Integrated EHR Prescription Modules, Cloud-based Prescription Software, Mobile Prescription Applications
- By End User: Hospitals, Clinics, Pharmacies, Individual Healthcare Practitioners, Telemedicine Providers
- By Deployment Mode: On-Premise, Cloud-Based, Hybrid
- By Therapeutic Area: General Medicine, Oncology, Cardiology, Psychiatry, Pediatrics
- By Features: Drug Interaction Checking, E-Prescribing, Clinical Decision Support, Patient History Management, Formulary Management
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Standalone Prescription Writing Software leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Prescription Writing Software Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
End User 5
Deployment Mode 3
Therapeutic Area 5
Features 5
Companies profiled
Epic Systems Corporation
Cerner Corporation (now part of Oracle)
Allscripts Healthcare Solutions
McKesson Corporation
eClinicalWorks
athenahealth (a Veritas Capital portfolio company)
NextGen Healthcare
GE Healthcare
Practice Fusion (acquired by Allscripts)
DrFirst
Meditech
Greenway Health
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cerner Corporation (now part of Oracle)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Allscripts Healthcare Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →McKesson Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →eClinicalWorks
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →athenahealth (a Veritas Capital portfolio company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NextGen Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Practice Fusion (acquired by Allscripts)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →DrFirst
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Meditech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Greenway Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Surescripts
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Zocdoc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →AdvancedMD
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,591M by 2033 · 7.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Standalone Prescription Writing Software75.5
- Integrated EHR Prescription Modules7.9
- Cloud-based Prescription Software8.4
- Mobile Prescription Applications8.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$286.3M → $558.4M · 8.7%
Europe$199.6M → $327.5M · 6.4%
Asia Pacific$182.2M → $359.8M · 8.9%
Latin America$112.8M → $225.3M · 9.0%
Middle East and Africa$86.8M → $167.0M · 8.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.822026
7.852027
7.862028
7.862029
7.872030
7.902031
7.912032
7.902033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Epic Systems Corporation19.1
- Cerner Corporation (now part of Oracle)19.7
- Allscripts Healthcare Solutions11.0
- McKesson Corporation6.0
- eClinicalWorks9.6
- athenahealth (a Veritas Capital portfolio company)6.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type27.3%
End User32.5%
Deployment Mode14.1%
Therapeutic Area14.0%
Features12.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.1
- Europe20.0
- Asia Pacific22.0
- Latin America13.8
- Middle East and Africa10.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Epic Systems Corporation | 88 | 77 | 88 | 87 | 83 | 98 | 87 |
| Cerner Corporation (now part of Oracle) | 91 | 70 | 90 | 93 | 88 | 70 | 84 |
| Allscripts Healthcare Solutions | 86 | 69 | 83 | 64 | 79 | 82 | 77 |
| McKesson Corporation | 62 | 81 | 80 | 60 | 75 | 77 | 73 |
| eClinicalWorks | 57 | 68 | 75 | 62 | 72 | 71 | 68 |
| athenahealth (a Veritas Capital portfolio company) | 59 | 47 | 68 | 47 | 58 | 46 | 54 |
| NextGen Healthcare | 62 | 43 | 58 | 55 | 64 | 45 | 55 |
| GE Healthcare | 58 | 41 | 51 | 52 | 51 | 36 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Epic Systems Corporation
- Cerner Corporation (now part of Oracle)
- Allscripts Healthcare Solutions
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Epic Systems Corporation | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Cerner Corporation (now part of Oracle) | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Allscripts Healthcare Solutions | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| McKesson Corporation | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| eClinicalWorks | ◐ | − | ◐ | − | ◐ | ◐ |
| athenahealth (a Veritas Capital portfolio company) | − | − | ✓ | − | − | ◐ |
| NextGen Healthcare | ◐ | ◐ | ◐ | − | ◐ | − |
| GE Healthcare | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Epic Systems Corporation87
2Cerner Corporation (now part of Oracle)84
3Allscripts Healthcare Solutions77
4McKesson Corporation73
5eClinicalWorks68
6NextGen Healthcare55
7athenahealth (a Veritas Capital portfolio company)54
8GE Healthcare48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Epic Systems CorporationCerner Corporation (now part of Oracle)
Challenger3
Strong scale, closing on the leaders.
Allscripts Healthcare SolutionsMcKesson CorporationeClinicalWorks
Niche3
Specialists in a single segment or region.
athenahealth (a Veritas Capital portfolio company)NextGen HealthcareGE Healthcare
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Prescription Writing Software Market — a $422M beachhead inside a $7.91B market.
Beachhead (SOM)$422Mobtainable near-term
Serviceable (SAM)$2.73Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Standalone Prescription Writing Software
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Integrated EHR Prescription Modules
Strong fit — clear ROI and a fast path to value.
End user65 fit
Cloud-based Prescription Software
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Deployment Mode
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Prescription Writing Software Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation12%
Closed-won5%
$21.5KCAC
$124KLTV
5.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Prescription Writing Software Market is a durable-growth opportunity — $7.51B by 2033, compounding at 9.4%.
TAM · 2025$3.65Btoday
TAM · 2033$7.51Bforecast
CAGR9.4%2027–2033
Cumulative$48.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.51BTotal addressable market
SAM$2.62BServiceable available market
SOM$559MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.51BLarge & growingTAM by 2033 at 9.4% CAGR
$2.62BServiceable nowreachable with today’s model
$559MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.86BBear6.1% CAGR
$7.51BBase9.4% CAGR
$9.61BBull12.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Prescription Writing Software Market — a $2.17B market by 2033. Plan: grow share from 8.9% to 15.3%.
Market size · 2033$2.17Btotal addressable
Market CAGR5.9%2027–2033
Target share15.3%from 8.9% today
Revenue ambition$332Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 15.3% | Behind |
| Revenue | $181M | $332M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.9% | 39.0% | On track |
| Customer retention | 91.5% | 93.2% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $37M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Prescription Writing Software Market conversation — a $6.33B market you can size, segment and defend in minutes.
Market size · 2033$6.33Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,117+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 2 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Epic Systems CorporationCerner Corporation (now part of Oracle)Allscripts Healthcare SolutionsMcKesson CorporationeClinicalWorksathenahealth (a Veritas Capital portfolio company)NextGen HealthcareGE Healthcare+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Prescription Writing Software Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Prescription Writing Software Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Adenine Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportAdenine (CAS 73-24-5) Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportPrimary Care EHR Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportAdenine Active Pharmaceutical Ingredient Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAdemetionine Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportAdemetionine Disulfate Tosylate Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportPsychiatry EMR Software Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportAdelmidrol Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportOperating Theatre Management System (OTMS) Market
Market size, share, segmentation and regional forecast.
$891M market · 2025 base year
View reportAdefovir Dipivoxil Tablet Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportQuality Assurance Service Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportDental Digital Treatment Software Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.